(Q47601713)

4 February 2018

title

Patterns of DST positivity in remitted affective disorders. (English)

1 reference

4 February 2018

author name string

Deshauer D

1

1 reference

4 February 2018

Grof E

2

1 reference

4 February 2018

Alda M

3

1 reference

4 February 2018

Grof P

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 April 1999

1 reference

4 February 2018

published in

Biological Psychiatry

1 reference

4 February 2018

volume

45

1 reference

4 February 2018

page(s)

1023-1029

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Oral contraceptives and the dexamethasone suppression test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The relationships of neuroendocrine tests in endogenous depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Serial dexamethasone suppression tests in psychiatric illness: Part I. A study in schizophrenia and mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Serial dexamethasone suppression tests in psychiatric illness: Part II. A study in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Glucocorticoids and the genesis of depressive illness. A psychobiological model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

A diagnostic interview: the schedule for affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Prolactin response to hypoglycemia in acute depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Neuroendocrine responses as an indicator of recurrence liability in primary affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Neuroendocrine strategies in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Lithium response and genetics of affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients - physiological and clinical construct validity of the DST.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The effect of age on cortisol and plasma dexamethasone concentrations in depressed patients and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Impact of circulating corticosterone on alpha 1- and alpha 2-noradrenergic receptors in discrete brain areas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Peak amplitude and frequency of urinary free cortisol excretion in patients with a history of major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The relationship of endogenous cortisol to psychiatric disorder: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Drugs and the DST: need for a reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Steroid hormone actions on the brain: when is the genome involved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Correlation between the dexamethasone suppression test in depressed patients and clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

How to Evaluate a Diagnostic Marker Test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The dexamethasone suppression test as a monitor of clinical recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The DST as a predictor of outcome in depression: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Pretreatment DST and Hypothalamic-Pituitary-Adrenocortical Function in Depressed Patients and Comparison Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Menstrual cycle effects on the dexamethasone suppression test in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Influence of age and relative weight on cortisol suppression in normal subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Normalization of the dexamethasone suppression test at discharge from hospital. Its prognostic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

Past and present strategies of research on the HPA-axis in psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900334-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(98)00334-5

1 reference

4 February 2018

PubMed ID

10386185

1 reference

4 February 2018